Global Skin Biopsy Market, By Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy, Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Curettes and Punches, Guidance Systems, Biopsy Forceps, Biopsy Needles and Others), Indication (Actinic Keratosis, Dermatitis, Psoriasis, Skin Infection, Cancer, Others), End User (Hospitals, Dermatology Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The skin biopsy market is expected to witness market growth at a rate of 8.40% in the forecast period of 2021 to 2028 and is expected to reach USD 785.34 million by 2028. Data Bridge Market Research report on skin biopsy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increasing prevalence of various types of cancer is escalating the growth of skin biopsy market.
Skin biopsy refers to a procedure that involves the removing of skin for examination and providing information regarding any disease or clinical conditions. The procedure is performed in order to determine the presence of any cancerous cells or any type of skin diseases. Various diseases can be diagnosed through skin biopsy such as actinic keratosis, dermatitis, cancer and skin infections. The sample taken from the affected or diseased part of the skin during the procedure is placed in formaldehyde solution. Then, the tissue is processed and examined under the microscope.
The growing incidences of skin cancer and number of skin disease such as psoriasis, viral skin infection and dermatitis and increasing demand for minimally invasive medical procedures act as the major factors driving the growth of skin biopsy market. The high usage of the biopsy to diagnose cancer and help distinguish healthy cells or calluses from tumorous cells and the increasing adoption of the procedure by interventional radiologists and the diagnostic department with the purpose of identifying diseases for a healthcare institution such as medical clinics, diagnostic centers and hospitals accelerate the skin biopsy market growth. The emergence of more than 100 types of cancers classified by their various organs including malignant melanoma of the colon and rectum among others and availability of several biopsies such as shave biopsy, punch biopsy, excisional biopsy and incisional biopsy further influence the skin biopsy market. Additionally, growing population, rising awareness about various diseases, unhealthy lifestyle, growing number of cancer awareness campaigns and surge in healthcare expenditure positively affects the skin biopsy market. Furthermore, technological advancement in the instruments extends profitable opportunity to the skin biopsy market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the procedure and treatment is expected to obstruct the skin biopsy market growth. The issues with the inadequate material collected and not inclusion of the deeper tissue in the biopsy is projected to challenge the skin biopsy market in the forecast period of 2021-2028.
This skin biopsy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on skin biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Skin Biopsy Market Scope and Market Size
The skin biopsy market is segmented on the basis of type, device, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.
- On the basis of device, the skin biopsy market is segmented into biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.
- On the basis of indication, the skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer and others. Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma and melanoma.
- On the basis of end user, the skin biopsy market is segmented into hospitals, dermatology clinics and others.
Global Skin Biopsy Market Country Level Analysis
The skin biopsy market is analyzed and market size insights and trends are provided by country, type, device, indication and end user as referenced above.
The countries covered in the global skin biopsy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the skin biopsy market because of the increasing prevalence of cancer, increasing prevalence of cancer, growing number of technologically advanced minimally invasive biopsy procedures, raising awareness about cancer screening programs and availability of early diagnostic procedures. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021 to 2028 due to the surge in healthcare spending, increasing government initiatives, availability of technologically enhanced smart biopsy devices and growth in awareness campaigns regarding cancer in the region.
The country section of the skin biopsy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The skin biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for skin biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on skin biopsy market. The data is available for historic period 2011-2019.
Competitive Landscape and Skin Biopsy Market Share Analysis
The skin biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to skin biopsy market.
The major players covered in the skin biopsy market report are BD, Gallini Srl, Boston Scientific Corporation, Cook, DTR Medical Ltd, Devicor Medical Products, Inc., Leica Biosystems Nussloch GmbH, Hologic, Inc., Cardinal Health, Danaher, innoMedicus Ltd, Intuitive Surgical, CANON MEDICAL SYSTEMS CORPORATION, iSYS Medizintechnik GmbH, Biosystems, Inc among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.